Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries posted on Wednesday a rise of 34.4% in its profits for the first eleven months of fiscal year 2016/2017 to EGP 81.6 million, versus EGP 60.7 million for the same period in FY15/16.
Revenues for the first eleven months of FY16/17 increased to EGP 509.3 million from EGP 401.3 million for the same period last year, according to a bourse filing.
The company had earlier reported a net profit of EGP 79.54 million for the first ten months of FY16/17.
The company’s stock fell on Tuesday by 0.59% to EGP 83.23.
